Jul 12, 2024 06:22AM Nurix (NRIX) PT Raised to $27 at RBC Capital

Jun 27, 2024 06:15AM Nurix (NRIX) PT Raised to $26 at RBC Capital

Jun 11, 2024 06:11AM RBC Capital Reiterates Outperform Rating on Nurix (NRIX)

May 7, 2024 07:00AM Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Apr 16, 2024 06:21PM Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Apr 12, 2024 05:58AM Nurix Therapeutics (NRIX) Prices Upsized 10.17M Share Offering at $15/sh

Apr 11, 2024 11:38PM Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering

Apr 11, 2024 04:00PM Nurix Therapeutics (NRIX) Announces Proposed $125M Share Offering

Apr 11, 2024 04:00PM Nurix Therapeutics Announces Proposed Public Offering

Apr 11, 2024 06:28AM Nurix (NRIX) PT Raised to $23 at RBC Capital

May 9, 2023 04:01PM Nurix Therapeutics to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

May 11, 2022 04:02PM Nurix Therapeutics Announces Participation in the 2022 RBC Capital Markets Global Healthcare Conference

Apr 18, 2022 06:47AM Nurix (NRIX) PT Lowered to $39 at RBC Capital

May 11, 2021 07:00AM Nurix Therapeutics to Participate in Upcoming Investor Conferences

Apr 30, 2021 05:43AM RBC Capital Starts Nurix (NRIX) at Outperform

Mar 9, 2021 04:01PM Nurix Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Mar 5, 2021 05:56AM Nurix Therapeutics (NRIX) Prices 4.5M Share Upsized Common Offering at $31/Sh

Mar 4, 2021 08:01PM Nurix Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Mar 2, 2021 04:16PM Nurix Therapeutics (NRIX) Announces Launch of Proposed Public Offering of Common Stock

Mar 2, 2021 04:15PM Nurix Therapeutics Announces Launch of Proposed Public Offering of Common Stock